BackPark Ha Biological Technology , Ltd. Overview
Park Ha Biological Technology Co., Ltd.

Park Ha Biological Technology , Ltd. Return on Equity

Latest ROE for Park Ha Biological Technology , Ltd.: -3293.78% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-3293.78%

Return on Equity

-3293.78%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Park Ha Biological Technology , Ltd. (PHH) FAQ

The latest ROE for PHH is -3293.78%. That is below the sector sector average of 11.75%. Investors often review this figure alongside Park Ha Biological Technology , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, PHH currently prints -3293.78% for ROE, while the sector average sits near 11.75%. That is roughly 28122.2% below the sector mean. Large gaps often invite a closer look at Park Ha Biological Technology , Ltd.'s growth, margins, and balance sheet.

Return on Equity shows how effectively Park Ha Biological Technology , Ltd. converts resources into returns. At -3293.78%, PHH may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PHH's ROE (-3293.78%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.